EUVIMEDEUVIMED entdecken
Crossref

News From the Society of Surgical Oncology (SSO) Annual Cancer Symposium (March 15-18, 2017 Seattle, WA): A New Hope—Neoadjuvant BRAF/MEK Inhibition for BRAF-Mutated Stage III Melanoma

Alexander C.J. van Akkooi

Clinical Skin Cancer · 2016

DOI: 10.1016/j.clsc.2017.04.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Skin Cancer, 2016. Verfasst von Alexander C.J. van Akkooi. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Akkooi, A. C. V. (2016). News From the Society of Surgical Oncology (SSO) Annual Cancer Symposium (March 15-18, 2017 Seattle, WA): A New Hope—Neoadjuvant BRAF/MEK Inhibition for BRAF-Mutated Stage III Melanoma. Clinical Skin Cancer. https://doi.org/10.1016/j.clsc.2017.04.003

Vancouver

Akkooi ACV. News From the Society of Surgical Oncology (SSO) Annual Cancer Symposium (March 15-18, 2017 Seattle, WA): A New Hope—Neoadjuvant BRAF/MEK Inhibition for BRAF-Mutated Stage III Melanoma. Clinical Skin Cancer. 2016. doi:10.1016/j.clsc.2017.04.003

BibTeX
@article{Akkooi2016,
  author = {Akkooi, Alexander C.J. van},
  title = {News From the Society of Surgical Oncology (SSO) Annual Cancer Symposium (March 15-18, 2017 Seattle, WA): A New Hope—Neoadjuvant BRAF/MEK Inhibition for BRAF-Mutated Stage III Melanoma},
  journal = {Clinical Skin Cancer},
  year = {2016},
  doi = {10.1016/j.clsc.2017.04.003}
}
Kostenlos starten →